A Propensity Score Analysis of Chemotherapy Use in Patients With Resectable Gallbladder Cancer is a research paper published in JAMA Network Open (2022). On theSindex it has a DataRank of 1.9. It has been cited 41 times, with 41 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.561
From this paper's citation signal
Citation Network Contribution
1.4
From 26 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 41 citers.
NCI NIH HHS
Grant: P30 CA142543
NCATS NIH HHS
Grant: UL1 TR003163
NCATS NIH HHS
Grant: UL1 TR001105
MeSH Terms
Additional file 1 of Residual cancer is a strong predictor of survival in T3 incidental gallbladder cancer
Additional file 1 of Residual cancer is a strong predictor of survival in T3 incidental gallbladder cancer